NCT01497769View on ClinicalTrials.gov

Safety of Tuberculosis Vaccine, MVA85A, Administered by the Aerosol Route and the Intradermal Route

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

April 30, 2013

Conditions
Tuberculosis
Interventions
BIOLOGICAL

Aerosol inhaled MVA85A

Aerosol inhaled MVA85A 1 x 10\^7 pfu and intradermal saline placebo

BIOLOGICAL

Intradermal MVA85A

Intradermal MVA85A 1 x 10\^7 pfu and inhaled aerosol saline placebo

Trial Locations (1)

Unknown

Centre of Clinical Vaccinology and Tropical Medicine (CCVTM) Churchill Hospital, Oxford

All Listed Sponsors
lead

University of Oxford

OTHER

NCT01497769 - Safety of Tuberculosis Vaccine, MVA85A, Administered by the Aerosol Route and the Intradermal Route | Biotech Hunter | Biotech Hunter